LORI MUSORRAFITI: Open Payments
NPI 1992239180 · MIDDLETOWN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,338 in 186 payments from 19 companies in 2025. Trend: 2023 $1,537 · 2024 $3,524 · 2025 $5,338
Food & beverage: $5,338
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 77 | $2,127 |
| AstraZeneca Pharmaceuticals LP | 33 | $1,337 |
| Indivior Inc. | 11 | $302 |
| Neurocrine BioSciences, Inc. | 4 | $189 |
| Corcept Therapeutics | 10 | $177 |
| Braeburn Inc. | 7 | $156 |
| Novo Nordisk Inc | 6 | $151 |
| Axsome Therapeutics, Inc. | 3 | $149 |
| Otsuka America Pharmaceutical, Inc. | 7 | $143 |
| Lilly USA, LLC | 6 | $128 |
Products named: VRAYLAR, TEZSPIRE, SUBLOCADE, BREZTRI, INGREZZA, AIRSUPRA, Korlym, BRIXADI.
Industry payments across NY — which companies pay providers there.
